Sol-Gel Technologies Competitors and Similar CompaniesClear all
Sol-Gel Technologies's competitors and similar companies include dMed, SciClone Pharmaceuticals, STADA and Apeloa Pharmaceutical.
 Sol-Gel Technologies Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. |  dMed dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. |  SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. |  Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products. | ||
Founding Date | Founding Date 1997 | Founding Date 2016 | Founding Date 1989 | Founding Date 1895 | Founding Date 1989 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Ness Ziona, IL HQ | Locations Morrisville, US HQ | Locations Foster City, US HQ | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more | Locations CN HQ |
Employees | Employees 34 | Employees 172 | Employees 1102% decrease | Employees 12,33911% increase | Employees 7,060 |
Valuation ($) | Valuation ($) 18 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 6 b | Valuation ($) 2.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $19.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $160.1m (FY, 2016) | Revenue (est.) €3b (FY, 2020) | Revenue (est.) ¥9.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods €1.3b (FY, 2020) | Cost of goods ¥7.2b (FY, 2025) |
Gross profit | Gross profit $19.4m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit €1.7b (FY, 2020) | Gross profit ¥2.5b (FY, 2025) |
Net income | Net income ($6.1m) (FY, 2025) | Net income N/A | Net income $30.7m (FY, 2016) | Net income €181.9m (FY, 2020) | Net income ¥890.7m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
dMed
HQ
Morrisville, US
Employees
172
dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities.
View companySciClone Pharmaceuticals
HQ
Foster City, US
Employees
110↓ 2% decrease
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
View company
STADA
HQ
Bad Vilbel, DE
Employees
12,339↑ 11% increase
STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
View companyApeloa Pharmaceutical
HQ
CN
Employees
7,060
Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.
View company